ImmuCell Corporation held its 2025 Annual Meeting of Stockholders on June 12, 2025, via remote communication. During the meeting, stockholders voted on several proposals. The election of the seven nominees as Directors of the Company was approved. An amendment to increase the number of shares reserved under the Company's 2017 Stock Option and Incentive Plan was not approved. The selection of Wipfli LLP as the Independent Registered Public Accounting Firm for the year ending December 31, 2025, was ratified.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.